BID
BID (BH3 interacting domain death agonist) is a pro-apoptotic member of the BCL-2 family of cell death regulators. It induces ICE-like proteases and apoptosis, and links caspase-8 activity to mitochondrial damage. Browse Assay Genie's current range of BID research reagents below, or read on for the biology behind the target.
BID is a death agonist that induces ICE-like proteases and apoptosis. It belongs to the BCL-2 family of cell death regulators and heterodimerises with either the agonist BAX or the antagonist BCL2, and in this way helps to regulate apoptosis. HGNC places it in the BCL2 homology region 3 (BH3) only group.
BID is a mediator of mitochondrial damage induced by caspase-8 (CASP8). CASP8 cleaves the BID protein, and the COOH-terminal part then translocates to mitochondria, where it triggers cytochrome c release. This cleavage step connects upstream caspase signalling to the mitochondrial arm of apoptosis, which makes BID a useful readout when studying how cell death signals are passed between these compartments. UniProt records the protein in the cytoplasm and at the mitochondrion membrane, including the outer membrane.
The human BID gene is also classed by HGNC among receptor ligands and among microRNA protein coding host genes. Multiple alternatively spliced transcript variants have been found, so researchers working with BID antibody or BID ELISA kit reagents should consider which forms they wish to detect. Mouse and rat each have a Bid ortholog, allowing the same pathway to be studied in common model systems.
BID induces ICE-like proteases and apoptosis, making it a central protein for studying how cell death is initiated and regulated.
CASP8 cleaves BID, and its COOH-terminal part moves to mitochondria, so BID is used to follow caspase-8-driven death signals.
The cleaved BID fragment triggers cytochrome c release from mitochondria, a key step in mitochondrial damage and apoptosis.
BID heterodimerises with BAX or BCL2, offering a model for how BH3-only proteins balance pro- and anti-apoptotic activity.
BID is a death agonist of the BCL-2 family that induces ICE-like proteases and apoptosis. It heterodimerises with BAX or BCL2 to regulate apoptosis, and after caspase-8 cleavage its COOH-terminal part moves to mitochondria and triggers cytochrome c release.
The approved name is BH3 interacting domain death agonist, and UniProt uses BH3-interacting domain death agonist. No other aliases or previous symbols are listed. NCBI Gene reports multiple alternatively spliced transcript variants for the BID gene.
Yes. Mouse and rat both carry a Bid ortholog, so the protein can be studied in common rodent models. Check the datasheet of any product for its validated reactivity before choosing a reagent for a given species.
Other BCL-2 family members, caspases and mitochondrial apoptosis markers that work alongside BID.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P55957; product specifications from Assay Genie datasheets.